Restricted accessResearch articleFirst published online 2012-09
Ala / Ala Genotype of Pro12Ala Polymorphism in the Peroxisome Proliferator-Activated Receptor - γ2 Gene Is Associated with Obesity and Insulin Resistance in Asian Indians
We determined the association of the Pro12Ala polymorphism of the peroxisome proliferator activated receptor (PPAR)-γ2 gene with obesity, insulin resistance (IR), and lipids in Asian Indians without diabetes in north India.
Subjects and Methods:
In this cross-sectional study (n=495; 279 males and 216 females, 18–60 years of age), anthropometric (body mass index, waist and hip circumferences, and skinfold thickness) and biochemical (fasting glucose, lipid profile, fasting insulin, leptin, and adiponectin) parameters were assessed. Polymerase chain reaction–restriction fragment length polymorphism analysis was used for identification of individual genotypes.
Results:
Frequencies of the Pro and Ala alleles were 0.89 and 0.11, respectively. The genotype frequencies (%) of Pro/Pro, Pro/Ala, and Ala/Ala were 82.6, 14.7, and 2.7, respectively, without any gender differences. The frequency of the Ala/Ala genotype was higher in obese than in nonobese subjects (4.9% vs. 1.5%, P=0.06). The Ala/Ala genotype was associated with higher values of hip circumference, subscapular skinfold thickness, and sum of four skinfold thickness than the Pro/Pro and Pro/Ala genotypes (P<0.05). Using a multivariate logistic regression model after adjusting for age, sex, and insulin, subjects with the Ala/Ala genotype showed a high risk of obesity (odds ratio [OR], 3.2, 95% confidence interval [CI] 1.2–12.9) and IR (OR, 3.6, 95% CI: 1.04–12.4).
Conclusion:
The Ala/Ala genotype of the PPAR-γ2 gene is associated with obesity and IR in Asian Indians without diabetes living in north India.
Get full access to this article
View all access options for this article.
References
1.
AnavianJ, BrennerDJ, FortP, SpeiserPW. Profiles of obese children presenting for metabolic evaluation. J Pediatr Endocrinol Metab, 2001; 14:1145–1150.
2.
FreedmanDS, DietzWH, SrinivasanSR, BerensonGS. The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study. Pediatrics, 1999; 103:1175–1182.
3.
SpiegelmanB, FlierJ. Adipogenesis and obesity: rounding out the big picture. Cell, 1996; 87:377–389.
4.
RibonV, JohnsonJH, CampHS, SaltielAR. Thiazolidinediones, and insulin resistance: PPARγ activation stimulates expression of the CAP gene. Proc Natl Acad Sci U S A, 1998; 95:14751–14756.
5.
FajasL, AuboeufD, RaspéE, SchoonjansK, LefebvreAM, SaladinR, NajibJ, LavilleM, FruchartJC, DeebS, Vidal-PuigA, FlierJ, BriggsMR, StaelsB, VidalH, AuwerxJ. The organization, promoter analysis, and expression of the human PPAR γ gene. J Biol Chem, 1997; 272:18779–18789.
6.
RuschkeK, FishbeinL, DietrichA, KlötingN, TönjesA, OberbachA, FasshauerM, JenknerJ, SchönMR, StumvollM, BlüherM, MantzorosCS. Gene expression of PPAR gamma and PGC-1 alpha in human omental and subcutaneous adipose tissues is related to insulin resistance markers and mediates beneficial effects of physical training. Eur J Endocrinol, 2010; 162:515–523.
7.
OlefskyJM. Treatment of insulin resistance with peroxisome proliferator-activated receptor γ agonists. J Clin Invest, 2000; 106:467–472.
8.
MollerDE, BergerJP. Role of PPARs in the regulation of obesity-related insulin sensitivity and inflammation. Int J Obes Relat Metab Disord, 2003; 27,Suppl 3:S17–S21.
9.
TellecheaML, ArangurenF, PérezMS, CerroneGE, FrechtelGD, TavernaMJ. Pro12Ala polymorphism of the peroxisome proliferator activated receptor-gamma gene is associated with metabolic syndrome and surrogate measures of insulin resistance in healthy men: interaction with smoking status. Circ J, 2009; 73:2118–2124.
10.
Ben AliS, Ben YahiaF, SediriY, KallelA, FtouhiB, FekiM, ElasmiM, Haj-TaiebS, SouheilO, SanhagiH, SlimaneH, JemaaR, KaabachiN. Gender-specific effect of Pro12Ala polymorphism in PPAR γ 2 gene on obesity risk and leptin levels in a Tunisian population. Clin Biochem, 2009; 42:1642–1647.
11.
BeamerBA, YenCJ, AndersenRE, MullerD, ElahiD, CheskinLJ, AndresR, RothJ, ShuldinerAR. Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations. Diabetes, 1998; 47:1806–1808.
12.
DeebSS, FajasL, NemotoM. A Pro12Ala substitution in PPAR γ 2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet, 1998; 20:284–287.
13.
BarrosoI, GurnellM, CrowleyVE, AgostiniM, SchwabeJW, SoosMA, MaslenGL, WilliamsTD, LewisH, SchaferAJ, ChatterjeeVK, O'RahillyS. Dominant negative mutations in human PPAR γ associated with severe insulin resistance, diabetes mellitus and hypertension. Nature, 1999; 402:880–883.
14.
HaseebA, IliyasM, ChakrabartiS, FarooquiAA, NaikSR, GhoshS, SuraganiM, EhteshamNZ. Single-nucleotide polymorphisms in peroxisome proliferator-activated receptor γ and their association with plasma levels of resistin and the metabolic syndrome in a South Indian population. J Biosci, 2009; 34:405–414.
15.
MisraA, KhuranaL. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab, 2008; 93,11 Suppl 1:S9–S30.
16.
DudejaV, MisraA, PandeyRM, DevinaG, KumarG, VikramNK. BMI does not accurately predict overweight in Asian Indians in Northern India. Br J Nutr, 2001; 86:105–112.
17.
MisraA, PandeyRM, DeviJR, SharmaR, VikramNK, KhannaN. High prevalence of diabetes, obesity, dyslipidaemia in urban slum population in Northern India. Int J Obes Relat Metab Disord, 2001; 25:1722–1729Erratum in Int J Obes Relat Metab Disord 2002;26:1281.
18.
VikramNK, MisraA, PandeyRM, DwivediM, LuthraK, DhingraV, TalwarKK. Association between subclinical inflammation & fasting insulin in urban young adult North Indian males. Indian J Med Res, 2006; 124:677–682.
19.
MisraA, AroraN, MondalS, PandeyRM, JailkhaniB, PeshinS, ChaudharyD, SalujaT, SinghP, ChandnaS, LuthraK, VikramNK. Relation between plasma leptin and anthropometric and metabolic covariates in lean and obese diabetic and hyperlipidaemic Asian Northern Indian subjects. Diabetes Nutr Metab, 2001; 14:18–26.
20.
VikramNK, MisraA, PandeyRM, DwivediM, LuthraK. Adiponectin, insulin resistance, and C-reactive protein in postpubertal Asian Indian adolescents. Metabolism, 2004; 53:1336–1341.
21.
MillerSA, DykesDD, PoleskyHF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res, 1988; 16:1215.
22.
MisraA, VikramNK, GuptaR, PandeyRM, WasirJS, GuptaVP. Waist circumference cutoff points and action levels for Asian Indians for identification of abdominal obesity. Int J Obes (Lond), 2006; 30:106–111.
23.
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 2003; 26,Suppl 1:S5–S20.
24.
MatthewsDR, HoskerJP, RudenskiAS, NaylorBA, TreacherDF, TurnerRC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985; 28:412–419.
25.
VikramNK, MisraA, PandeyRM, LuthraK, BhattSP. Distribution of cutoff points of fasting insulin in Asian Indian adolescent and association with metabolic syndrome. J Assoc Physicians India, 2008; 56:949–954.
26.
FrederiksenL, BrødbaekK, FengerM, JørgensenT, Borch-JohnsenK, MadsbadS, UrhammerSA. Comment: studies of the Pro12Ala polymorphism of the PPAR-gamma gene in the Danish MONICA cohort: homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome. J Clin Endocrinol Metab, 2002; 87:3989–3992.
27.
TonjesA, ScholzM, StumvollM. Association of Pro12Ala polymorphism in peroxisome proliferator–activated receptor with pre-diabetic phenotypes. Diabetes Care, 2006; 29:2489–2497.
28.
MasudS, YeS. SAS Group. Effect of the peroxisome proliferator activated receptor gene Pro12Ala variant on body mass index: a meta-analysis. J Med Genet, 2003; 40:773–780.
29.
NelsonTL, FingerlinTE, MossL, BarmadaMM, FerrellRE, NorrisJM. The PPAR γ Pro12Ala polymorphism is not associated with body mass index or waist circumference among Hispanics from Colorado. Ann Nutr Metab, 2007; 51:252–257.
30.
ValveR, SiveniusK, MiettinenR, PihlajamäkiJ, RissanenA, DeebSS, AuwerxJ, UusitupaM, LaaksoM. Two polymorphisms in the peroxisome proliferator-activated receptor γ gene are associated with severe overweight among obese women. J Clin Endocrinol Metab, 1999; 84:3708–3712.
31.
MoriniE, TassiV, CapponiD, LudovicoO, DallapiccolaB, TrischittaV, PrudenteS. Interaction between PPAR γ 2 variants and gender on the modulation of body weight. Obesity (Silver Spring), 2008; 16:1467–1470.
32.
RadhaV, VimaleswaranKS, BabuHN, AbateN, ChandaliaM, SatijaP, GrundySM, GhoshS, MajumderPP, DeepaR, RaoSM, MohanV. Role of genetic polymorphism PPAR γ2 Pro12Ala on ethnic susceptibility to diabetes in South-Asian and Caucasian subjects: evidence for heterogeneity. Diabetes Care, 2006; 29:1046–1051.
33.
YangLL, HuaQ, LiuRK, YangZ. Association between two common polymorphisms of PPAR γ gene and metabolic syndrome families in a Chinese population. Arch Med Res, 2009; 40:89–96.
34.
González SánchezJL, Serrano RíosM, Fernández PerezC, LaaksoM, Martínez LarradMT. Effect of the Pro12Ala polymorphism of the PPAR γ2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population. Eur J Endocrinol, 2002; 147:495–501.
35.
HaraK, OkadaT, TobeK, YasudaK, MoriY, KadowakiH, HaguraR, AkanumaY, KimuraS, ItoC, KadowakiT. The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes. Biochem Biophys Res Commun, 2000; 271:212–216.
36.
MeirhaegheA, FajasL, HelbecqueN, CottelD, AuwerxJ, DeebSS, AmouyelP. Impact of the peroxisome proliferator activated receptor γ 2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus. Int J Obes Relat Metab Disord, 2000; 24:195–199.
37.
MisraA, VikramNK. Insulin resistance syndrome (metabolic syndrome) and obesity in Asian Indians: evidence and implications. Nutrition, 2004; 20:482–491.
38.
GoelK, MisraA, VikramNK, GuptaN. Subcutaneous abdominal adipose tissue is associated with the metabolic syndrome in Asian Indians independent of intra-abdominal and total body fat. Heart, 2010; 96:579–583.
39.
LuanJ, BrownePO, HardingAH, HalsallDJ, O'RahillyS, ChatterjeeVK, WarehamNJ. Evidence for gene-nutrient interaction at the PPARgamma locus. Diabetes, 2001; 50:686–689.
40.
LamriA, Abi KhalilC, JaziriR, VelhoG, LantieriO, VolS, FroguelP, BalkauB, MarreM, FumeronF. Dietary fat intake and polymorphisms at the PPARG locus modulate BMI and type 2 diabetes risk in the D.E.S.I.R. prospective study. Int J Obes (Lond), 2012; 36:218–224.
